BCL2L1 and neoplasm: IHC results demonstrated that ascorbate reduced the expression of Bcl-xL by 41.2% and 35.8% in EC tumor tissues of obese and lean LKB1fl/flp53fl/fl-mice, respectively, compared to control mice (Figure 2G, p<0.01).